These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7725021)

  • 41. Retroviruses in autoimmune liver disease: genetic or environmental agents?
    Mason AL; Xu L; Guo L; Garry RF
    Arch Immunol Ther Exp (Warsz); 1999; 47(5):289-97. PubMed ID: 10604234
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatitis B virus DNA integration in hepatocellular carcinoma after interferon-induced disappearance of hepatitis C virus.
    Tamori A; Nishiguchi S; Shiomi S; Hayashi T; Kobayashi S; Habu D; Takeda T; Seki S; Hirohashi K; Tanaka H; Kubo S
    Am J Gastroenterol; 2005 Aug; 100(8):1748-53. PubMed ID: 16086711
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hepatitis viruses: live and let die.
    Herzer K; Sprinzl MF; Galle PR
    Liver Int; 2007 Apr; 27(3):293-301. PubMed ID: 17355449
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modulation of MAPK pathways and cell cycle by replicating hepatitis B virus: factors contributing to hepatocarcinogenesis.
    Chin R; Earnest-Silveira L; Koeberlein B; Franz S; Zentgraf H; Dong X; Gowans E; Bock CT; Torresi J
    J Hepatol; 2007 Sep; 47(3):325-37. PubMed ID: 17512084
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
    Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
    Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The hepatitis B virus preS2/St transactivator utilizes AP-1 and other transcription factors for transactivation.
    Lauer U; Weiss L; Lipp M; Hofschneider PH; Kekulé AS
    Hepatology; 1994 Jan; 19(1):23-31. PubMed ID: 8276360
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Virologic analysis of non-B, non-C hepatocellular carcinoma in Japan: frequent involvement of hepatitis B virus.
    Yotsuyanagi H; Shintani Y; Moriya K; Fujie H; Tsutsumi T; Kato T; Nishioka K; Takayama T; Makuuchi M; Iino S; Kimura S; Koike K
    J Infect Dis; 2000 Jun; 181(6):1920-8. PubMed ID: 10837171
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Primary liver cancer. Pathogenetic and clinical aspects].
    Kozakiewicz H
    Pol Tyg Lek; 1981 Feb; 36(7):275-8. PubMed ID: 7022408
    [No Abstract]   [Full Text] [Related]  

  • 49. [Viral diseases and cancer risk].
    Meylan P
    Rev Med Suisse; 2016 Jan; 12(503):170-2. PubMed ID: 26939167
    [No Abstract]   [Full Text] [Related]  

  • 50. [The activity of enzymes in lymphocytes of children and adults with chronic viral hepatitis B and C].
    Bulygin VG; Tikhonova EP; Bulygin GV
    Klin Lab Diagn; 2012 Oct; (10):20-2. PubMed ID: 23265050
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The search for infectious causes of human cancers: where and why.
    Zur Hausen H
    Virology; 2009 Sep; 392(1):1-10. PubMed ID: 19720205
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatitis C virus associated with high rates of cancer.
    Burki TK
    Lancet Oncol; 2015 Jun; 16(6):e266. PubMed ID: 25936989
    [No Abstract]   [Full Text] [Related]  

  • 53. Does cirrhosis associated with well controlled viral hepatitis confer a risk for extrahepatic cancer?
    Yang JD; Gores GJ
    Hepatology; 2018 Oct; 68(4):1217-1219. PubMed ID: 29698552
    [No Abstract]   [Full Text] [Related]  

  • 54. Proceedings of the International Symposium on Molecular Biology of Hepatitis B Virus and Non-A Non-B Hepatitis Virus. June 1, 1989, Kanazawa, Japan.
    Gastroenterol Jpn; 1990 Sep; 25 Suppl 2():1-81. PubMed ID: 1977652
    [No Abstract]   [Full Text] [Related]  

  • 55. Indelibly Stamped by Hepatitis C Virus Infection: Persistent Epigenetic Signatures Increasing Liver Cancer Risk.
    Lohmann V; Bartenschlager R
    Gastroenterology; 2019 Jun; 156(8):2130-2133. PubMed ID: 31034828
    [No Abstract]   [Full Text] [Related]  

  • 56. Virus-like particles in the cells of a primary carcinoma of the liver.
    THERON JJ; PEPLER WJ; van der LIEBENBERG NW
    Nature; 1962 May; 194():489-90. PubMed ID: 13920567
    [No Abstract]   [Full Text] [Related]  

  • 57. Hepatitis and liver cancer link found.
    Nurs Stand; 1991 Jun; 5(38):16. PubMed ID: 27667619
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevalence of hepatitis B and C in blood transfusion center, Oujda Morocco (2013-2015).
    Boubker S; Zerrouki N; Sidqi Z; Moussi M; El Mekkaoui A; Khannoussi W; Kharrasse G; Ismaili Z
    Pan Afr Med J; 2019; 33():163. PubMed ID: 31565125
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Hepatitis B and C viruses and primary liver cancer].
    Bréchot C
    Rev Prat; 1995 Jan; 45(2):190-6. PubMed ID: 7725021
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatitis B virus-related hepatocellular carcinoma: paradigms for viral-related human carcinogenesis.
    Kremsdorf D; Soussan P; Paterlini-Brechot P; Brechot C
    Oncogene; 2006 Jun; 25(27):3823-33. PubMed ID: 16799624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.